本文選題：泡型包蟲病 + 自體肝移植　； 參考：《中國(guó)公共衛(wèi)生》2017年07期

【摘要】：目的針對(duì)終末期肝泡型包蟲病(HAE)患者實(shí)施自體肝移植(ALT)治療,探索其疾病經(jīng)濟(jì)負(fù)擔(dān)及其影響因素。方法收集2010年8月—2017年2月在新疆某三甲教學(xué)醫(yī)院住院并行ALT術(shù)治療的51例HAE患者的臨床資料及各項(xiàng)費(fèi)用數(shù)據(jù),計(jì)算患者直接經(jīng)濟(jì)負(fù)擔(dān)和間接經(jīng)濟(jì)負(fù)擔(dān),并對(duì)其影響因素進(jìn)行單因素分析。結(jié)果 51例ALT術(shù)治療的HAE患者經(jīng)濟(jì)負(fù)擔(dān)為447 128.89元;其中直接經(jīng)濟(jì)負(fù)擔(dān)257 943.45元(直接醫(yī)療費(fèi)用為257 292.09元、直接非醫(yī)療費(fèi)用為651.36元),占57.54%;間接經(jīng)濟(jì)負(fù)擔(dān)189 834.06元,占42.46%。住院天數(shù)、年齡和職業(yè)等是影響患者住院費(fèi)用的重要因素。結(jié)論 ALT術(shù)是一種有效解決終末期HAE的創(chuàng)新外科治療方法,其疾病直接經(jīng)濟(jì)負(fù)擔(dān)占的比重較高。通過(guò)以預(yù)防為主的同時(shí)針對(duì)接受ALT術(shù)的HAE患者加強(qiáng)醫(yī)療保障力度和提高救助標(biāo)準(zhǔn)等措施減輕患者的經(jīng)濟(jì)負(fù)擔(dān)。
[Abstract]:Objective to investigate the economic burden of liver disease and its influencing factors in patients with end-stage hepatic alveolar hydatid disease (HAE) treated with autologous liver transplantation (ALT). Methods from August 2010 to February 2017, the clinical data and various cost data of 51 patients with HAE who were hospitalized and treated with ALT in a teaching hospital of Xinjiang from August 2010 to February 2017 were collected, and the direct economic burden and indirect economic burden of the patients were calculated. The influencing factors were analyzed by single factor analysis. Results the economic burden of 51 HAE patients treated with ALT was 447 128.89 yuan, of which the direct financial burden was 257 943.45 yuan (the direct medical cost was 257 292.09 yuan, the direct non-medical cost was 651.36 yuan (57.54 yuan), and the indirect economic burden was 189 834.06 yuan (42.46%). The days of hospitalization, age and occupation are important factors affecting the cost of hospitalization. Conclusion ALT is an effective and innovative surgical treatment for end-stage HAE, and its direct economic burden is high. In order to alleviate the economic burden of HAE patients undergoing ALT operation, the measures of strengthening medical security and improving the standard of relief were taken to reduce the economic burden of the patients.
【作者單位】： 新疆醫(yī)科大學(xué)公共衛(wèi)生學(xué)院衛(wèi)生經(jīng)濟(jì)教研室;新疆醫(yī)科大學(xué)第一附屬醫(yī)院消化血管外科中心肝膽包蟲外科;新疆器官移植研究所;
【基金】：國(guó)家自然科學(xué)基金(U1303222) 教育部“長(zhǎng)江學(xué)者與創(chuàng)新團(tuán)隊(duì)發(fā)展計(jì)劃”項(xiàng)目(IRT1181)
【分類號(hào)】：R532.32;R657.3

【相似文獻(xiàn)】

相關(guān)重要報(bào)紙文章 前1條

1 記者 牛金輝;我區(qū)應(yīng)用自體肝移植技術(shù)治愈“蟲癌”[N];新疆科技報(bào)(漢);2008年

，

本文編號(hào)：1793003